U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Medical Devices
  3. Products and Medical Procedures
  4. Device Approvals and Clearances
  5. Recently-Approved Devices
  6. Altius Direct Electrical Nerve Stimulation System – P230020
  1. Recently-Approved Devices

Altius Direct Electrical Nerve Stimulation System – P230020

 

Figure 1: Altius System Components; Figure 2: Altius System Implant Location (Left: System Implantation; Right: Cuff Electrode on Nerve)

This is a brief overview of information related to the FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for the FDA’s approval.

Product Name: Altius Direct Electrical Nerve Stimulation System
PMA Applicant: Neuros Medical, Inc.
Address: 26800 Aliso Viejo Parkway, Suite 250, Aliso Viejo, CA 92656
Approval Date: August 26, 2024
Approval Letter: Approval Order

What is it?

The Altius Direct Electrical Nerve Stimulation System is an implantable device to help reduce long-term (chronic) and difficult to manage phantom limb pain and residual limb pain in the legs of adult amputees post-amputation.

The main components of the Altius System are:

  • an implanted pulse (signal) generator (IPG),
  • one or two implanted cuff electrodes and attached lead(s),
  • a battery pack and charger,
  • a controller used by the patient, and
  • a programmer wand used for communication between the programmer system (a program that provides a health care provider information)

 

Back to Top